VERTEX PHARMACEUTICALS INC (VX1.DE) Stock Balance Sheet
FRA:VX1 - Deutsche Boerse Ag - US92532F1003 - Common Stock - Currency: EUR
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.52B | 11.22B | 10.50B | 6.79B | 5.99B | |||
| Marketable Securities | 1.29B | 849.20M | 275.00M | 730.00M | 671.00M | |||
| Receivables | 1.75B | 1.56B | 1.44B | 1.14B | 885.00M | |||
| Inventories | 1.08B | 738.80M | 461.00M | 353.00M | 281.00M | |||
| Other Current Assets | 449.20M | 623.70M | 554.00M | 546.00M | 308.00M | |||
| Total Current Assets | 9.80B | 14.14B | 13.23B | 9.56B | 8.13B | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.51B | 1.45B | 1.46B | 1.42B | 1.28B | |||
| Investments And Advances | 4.78B | 2.60B | 99.00M | 86.00M | 21.00M | |||
| Goodwill | 1.09B | 1.09B | 1.09B | 1.00B | 1.00B | |||
| Intangibles | 831.60M | 839.90M | 604.00M | 400.00M | 400.00M | |||
| Other Non-Current Assets | 3.23B | 2.61B | 1.67B | 960.00M | 911.00M | |||
| Total Non-Current Assets | 12.44B | 8.59B | 4.92B | 3.87B | 3.62B | |||
| TOTAL ASSETS | 22.24B | 22.73B | 18.15B | 13.43B | 11.75B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 50.60M | 41.00M | 47.00M | 42.00M | |||
| Accrued Expenses | 3.22B | 2.59B | 2.05B | 1.50B | 1.31B | |||
| Accounts Payable | 4.01B | 3.39B | 304.00M | 195.00M | 155.00M | |||
| Other Current Liabilities | 357.60M | 543.00M | 345.00M | 400.00M | 369.00M | |||
| Total Current Liabilities | 3.97B | 3.55B | 2.74B | 2.14B | 1.88B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 114.00M | 376.10M | 431.00M | 510.00M | 539.00M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 2.52B | 1.23B | 1.06B | 681.00M | 648.00M | |||
| Total Non-Current Liabilities | 2.64B | 1.60B | 1.50B | 1.19B | 1.19B | |||
| TOTAL LIABILITIES | 6.61B | 5.15B | 4.24B | 3.33B | 3.06B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 8.69B | 10.14B | 6.52B | 3.20B | 859.00M | |||
| Additional Paid In Capital | 6.91B | 7.45B | 7.39B | 6.88B | 7.89B | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 2.60M | 2.60M | 3.00M | 3.00M | 3.00M | |||
| Other Shareholders' Equity | -22.40M | -23.90M | 1.00M | 16.00M | -69.00M | |||
| Shares Outstanding | 257.74M | 257.70M | 257.00M | 254.00M | 260.00M | |||
| Tangible Book Value per Share | 53.20 | 60.74 | 47.55 | 34.24 | 28.02 | |||
| Total Shareholders' Equity | 15.63B | 17.58B | 13.91B | 10.10B | 8.69B | |||
| TOTAL LIABILITIES AND EQUITY | 22.24B | 22.73B | 18.15B | 13.43B | 11.75B | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.02 | 0.03 | 0.05 | 0.06 | |||
| Current Ratio | 2.47 | 3.99 | 4.83 | 4.46 | 4.33 | |||
| Return On Assets (ROA) | -2.16% | 15.92% | 18.30% | 17.44% | 23.07% | |||
| Return On Equity (ROE) | -3.07% | 20.59% | 23.88% | 23.19% | 31.21% | |||
| Return On Invested Capital (ROIC) | 18.91% | 18.31% | 22.59% | 19.85% | 23.31% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 33.04% | 49.36% | 75.18% | 59.52% | 71.58% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 40.47% | 67.70% | 118.47% | 94.82% | 126.93% | |||
All data in USD , ROIC based on taxRate of 0.19